A retrospective study of 2228 cases with eyelid tumors.

AIM To describe the histopathologic and clinical features of eyelid tumor cases from Tianjin Eye Hospital during 2002 to 2015. METHODS In this retrospective study, a total of 2228 cases of eyelid tumors with pathologic diagnoses were enrolled. The eyelid tumors were classified into three groups according to tumor origin: epidermal, adnexal and miscellaneous, including melanocytic, neural and vascular lesions. Inflammatory tumor-like lesions were excluded. The clinical characteristics of the eyelid tumors were analyzed, including age, gender and lesion location. RESULTS Most eyelid tumors were epidermal in origin (1080, 48.5%), followed by miscellaneous (885, 39.7%) and adnexal tumors (263, 11.8%). Among all the tumors, 292 (13.1%) were malignant lesions, 1910 (85.7%) benign and 26 (1.1%) premalignant lesions. Most malignant tumors originated from epidermal cells (60.0%), followed by adnexal cells (34.6%). The most common malignant tumors were basal cell carcinomas (56.5%) followed by sebaceous carcinoma (34.6%), squamous cell carcinomas (3.8%) and lymphoma/plasmocytoma (1.7%). The benign and premalignant eyelid lesions mostly originated from epidermal cells (46.4%) followed by miscellaneous cell sources (45.2%), including melanocytic nevus (33.8%), seborrheic keratosis (13.7%), squamous cell papilloma (13.0%) and epidermal cysts (11.5%). CONCLUSION Eyelid tumors are mostly epithelial in origin. Benign tumors are significantly more common than malignant tumors with an obvious female predominance, and the most frequent malignant tumor are basal cell carcinoma, sebaceous carcinoma and squamous cell carcinomas. The tumor clinical features varied among the different subtypes.

[1]  K. Ahn,et al.  Clinical and Histopathological Investigation of Seborrheic Keratosis , 2016, Annals of dermatology.

[2]  S. Sporny,et al.  Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid , 2016, Postepy dermatologii i alergologii.

[3]  Chieh-Chih Tsai,et al.  Comparison of the Clinical Characteristics and Outcome of Benign and Malignant Eyelid Tumors: An Analysis of 4521 Eyelid Tumors in a Tertiary Medical Center , 2015, BioMed research international.

[4]  R. E. D. Domingo,et al.  Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review , 2015, Clinical ophthalmology.

[5]  Michelle T. Sun,et al.  Periocular Squamous Cell Carcinoma: TNM Staging and Recurrence. , 2015, Ophthalmology.

[6]  F. Şahin,et al.  Eyelid tumors: clinical data from an eye center in Ankara, Turkey. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[7]  A. Tatsioni,et al.  Eyelid Tumors at the University Eye Clinic of Ioannina, Greece: A 30-year Retrospective Study , 2015, Middle East African journal of ophthalmology.

[8]  L. Mogoantă,et al.  Histological and immunohistochemical study of the eyelid basal cell carcinomas. , 2015, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[9]  A. Mizota,et al.  Differentiation between chalazion and sebaceous carcinoma by noninvasive meibography , 2014, Clinical ophthalmology.

[10]  Philip R. Cohen,et al.  Malignancies of the eyelid: a review of primary and metastatic cancers , 2013, International journal of dermatology.

[11]  V. White,et al.  Periocular sebaceous gland carcinoma: A comprehensive review. , 2013, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[12]  Kana Takahashi,et al.  Results of radical radiotherapy for squamous cell carcinoma of the eyelid , 2012, Journal of radiation research.

[13]  S. Amrith,et al.  Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008 , 2012, British Journal of Ophthalmology.

[14]  Fabio Lavinsky,et al.  Histological and Clinical Features of Primary and Recurrent Periocular Basal Cell Carcinoma , 2012, ISRN ophthalmology.

[15]  Surendra B. Patil,et al.  Clinicopathological analysis of eyelid malignancies - A review of 85 cases , 2012, Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.

[16]  S. Mak,et al.  Malignant eyelid tumors in Hong Kong 1997–2009 , 2011, Japanese Journal of Ophthalmology.

[17]  S. Uffer,et al.  Clinicopathological Features of Eyelid Skin Tumors. A Retrospective Study of 5504 Cases and Review of Literature , 2009, The American Journal of dermatopathology.

[18]  C. Shields,et al.  Sebaceous Adenocarcinoma of the Eyelid , 2009, International ophthalmology clinics.

[19]  Xiao Lin Xu,et al.  Eyelid neoplasms in the Beijing Tongren Eye Centre between 1997 and 2006. , 2008, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[20]  Ching-Yu Cheng,et al.  Incidence of eyelid cancers in Taiwan: a 21-year review. , 2006, Ophthalmology.

[21]  T. Tsuru,et al.  [Incidence of benign and malignant lesions of eyelid and conjunctival tumors]. , 2005, Nippon Ganka Gakkai zasshi.

[22]  C. Shields,et al.  Sebaceous carcinoma of the eyelids: personal experience with 60 cases. , 2004, Ophthalmology.

[23]  S. Liao,et al.  Malignant eyelid tumours in Taiwan , 2003, Eye.

[24]  G. Bartley,et al.  Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. , 2001, Ophthalmology.

[25]  S. Saw,et al.  Incidence of eyelid cancers in Singapore from 1968 to 1995 , 1999, The British journal of ophthalmology.

[26]  S. Pieh,et al.  Long term results after surgical basal cell carcinoma excision in the eyelid region , 1999, The British journal of ophthalmology.

[27]  Y. Ohnishi,et al.  Malignant tumor of the eyelid--clinical survey during 22-year period. , 1983, Japanese journal of ophthalmology.